The Jain Foundation funds research projects targeting the mechanisms, diagnosis, and treatment of dysferlinopathies, supporting innovation from basic science to clinical application.
Funder: Jain Foundation
Due Dates: Rolling (proposals reviewed year-round)
Funding Amounts: No set minimum or maximum; award size and duration based on project needs; indirect costs are not covered.
Summary: Supports innovative basic, translational, and clinical research directly targeting mechanisms, diagnosis, or treatment of dysferlinopathies (LGMD2B, LGMDR2, Miyoshi Myopathy).
Key Information: Proposals must be directly relevant to dysferlinopathy; pre-proposals are encouraged for early feedback.
The Jain Foundation Research Grants program funds research projects that accelerate the development of treatments and cures for dysferlinopathies, including LGMD2B, LGMDR2, and Miyoshi Myopathy. The Foundation employs a non-traditional, collaborative funding model and actively supports projects in basic, translational, and clinical research that address disease mechanisms, diagnostics, and therapeutic interventions. All proposals are reviewed in-house by a specialized scientific advisory board, ensuring alignment with the Foundation’s mission to advance dysferlin research. The Foundation also provides researchers with access to unique resources, reagents, and a collaborative research community.